iBio (IBIO) Competitors $0.73 +0.01 (+0.98%) Closing price 04:00 PM EasternExtended Trading$0.73 -0.01 (-0.68%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock IBIO vs. AVTX, ATRA, CRVO, RENB, ZIVO, AADI, KLRS, BLUE, OSTX, and RNXTShould you be buying iBio stock or one of its competitors? The main competitors of iBio include Avalo Therapeutics (AVTX), Atara Biotherapeutics (ATRA), CervoMed (CRVO), Renovaro (RENB), ZIVO Bioscience (ZIVO), Aadi Bioscience (AADI), Kalaris Therapeutics (KLRS), bluebird bio (BLUE), OS Therapies (OSTX), and RenovoRx (RNXT). These companies are all part of the "pharmaceutical products" industry. iBio vs. Its Competitors Avalo Therapeutics Atara Biotherapeutics CervoMed Renovaro ZIVO Bioscience Aadi Bioscience Kalaris Therapeutics bluebird bio OS Therapies RenovoRx Avalo Therapeutics (NASDAQ:AVTX) and iBio (NYSE:IBIO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk. Which has more volatility and risk, AVTX or IBIO? Avalo Therapeutics has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, iBio has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Do institutionals & insiders hold more shares of AVTX or IBIO? 87.1% of Avalo Therapeutics shares are owned by institutional investors. Comparatively, 7.9% of iBio shares are owned by institutional investors. 0.3% of Avalo Therapeutics shares are owned by insiders. Comparatively, 0.6% of iBio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is AVTX or IBIO more profitable? Avalo Therapeutics' return on equity of 111.00% beat iBio's return on equity.Company Net Margins Return on Equity Return on Assets Avalo TherapeuticsN/A 111.00% 58.88% iBio N/A -73.15%-45.51% Which has stronger earnings & valuation, AVTX or IBIO? iBio has lower revenue, but higher earnings than Avalo Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvalo Therapeutics$440K119.38-$35.13MN/AN/AiBio$375K32.25-$24.91MN/AN/A Does the media refer more to AVTX or IBIO? In the previous week, Avalo Therapeutics had 1 more articles in the media than iBio. MarketBeat recorded 2 mentions for Avalo Therapeutics and 1 mentions for iBio. Avalo Therapeutics' average media sentiment score of 0.94 beat iBio's score of 0.00 indicating that Avalo Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avalo Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iBio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer AVTX or IBIO? Avalo Therapeutics currently has a consensus target price of $30.00, suggesting a potential upside of 518.56%. iBio has a consensus target price of $4.30, suggesting a potential upside of 487.43%. Given Avalo Therapeutics' higher possible upside, research analysts clearly believe Avalo Therapeutics is more favorable than iBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avalo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00iBio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAvalo Therapeutics beats iBio on 9 of the 12 factors compared between the two stocks. Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBIO vs. The Competition Export to ExcelMetriciBioPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$12.09M$752.24M$5.57B$20.66BDividend YieldN/A4.84%4.23%3.65%P/E RatioN/A1.4328.6427.28Price / Sales32.2525.51432.3454.68Price / CashN/A19.5636.0222.28Price / Book0.526.618.234.60Net Income-$24.91M-$4.53M$3.24B$995.22M7 Day Performance-12.38%1.65%0.05%-0.78%1 Month Performance-16.25%1.58%5.65%3.58%1 Year Performance-65.31%3.55%26.57%7.35% iBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBIOiBio1.2695 of 5 stars$0.73+1.0%$4.30+487.4%-68.4%$12.09M$375K0.00100AVTXAvalo Therapeutics3.1189 of 5 stars$4.75-4.2%$30.00+531.6%-60.8%$51.44M$440K0.0040ATRAAtara Biotherapeutics4.4012 of 5 stars$8.58+1.3%$17.75+106.9%-16.9%$51.14M$128.94M-2.31330News CoverageCRVOCervoMed3.28 of 5 stars$5.87+3.9%$27.63+370.6%-59.9%$51.09MN/A-2.694News CoveragePositive NewsRENBRenovaro1.8786 of 5 stars$0.30+2.6%N/A-80.0%$51.03MN/A-0.3920ZIVOZIVO BioscienceN/A$13.00+8.4%N/A+57.0%$49.62M$15.85K-2.6610AADIAadi Bioscience0.3713 of 5 stars$1.99+5.9%$1.67-16.2%+37.6%$49.15M$25.07M-0.8740KLRSKalaris TherapeuticsN/A$2.61+4.4%N/AN/A$48.81MN/A0.00110BLUEbluebird bio1.5718 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520OSTXOS Therapies2.2208 of 5 stars$1.73-5.5%$18.00+940.5%N/A$48.61MN/A-2.01N/AAnalyst ForecastRNXTRenovoRx2.5086 of 5 stars$1.32-2.9%$7.25+449.2%+3.9%$48.27M$40K-3.306 Related Companies and Tools Related Companies AVTX Alternatives ATRA Alternatives CRVO Alternatives RENB Alternatives ZIVO Alternatives AADI Alternatives KLRS Alternatives BLUE Alternatives OSTX Alternatives RNXT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IBIO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBIO Stock Alerts